Eton Pharmaceuticals, Inc. (ETON)

SEC filing

Eton Pharmaceuticals, Inc.

ETON · CIK 1710340

4 · Aug 24, 2026 · Chief Business Officer Krempa David sold 25K shares at $65.07/share ($1.6M); exercised options for 50K shares

Chief Business Officer Krempa David sold 25K shares at $65.07/share ($1.6M); exercised options for 50K shares

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).